# Acute Myocardial Necrosis and Depression: Antiplatelet Effect of Reuptake Inhibition of Serotonin

> **NCT02463110** · PHASE4 · TERMINATED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 2 (actual)

## Conditions studied

- Depression
- Coronary Artery Disease

## Interventions

- **DRUG:** Sertraline
- **DRUG:** No treatment
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02463110
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-07
- **Primary completion:** 2016-02
- **Final completion:** 2016-02
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Investigator's decision
- **Last updated:** 2016-05-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02463110

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02463110, "Acute Myocardial Necrosis and Depression: Antiplatelet Effect of Reuptake Inhibition of Serotonin". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT02463110. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*